6 results found.

Adult Primary Hepatocellular Carcinoma, Localized Unresectable Ad Clinical Trial using sorafenib tosylate; placebo; doxorubicin hydrochloride; doxorubicin-eluting beads; cisplatin; mitomycin C

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase III Randomized, Double-Blind Trial of Chemoembolization With or Without Sorafenib in Unresectable Hepatocellular Carcinoma (HCC) in Patients With and Without Vascular Invasion.
sorafenib tosylate; placebo; doxorubicin hydrochloride; doxorubicin-eluting beads; cisplatin; mitomycin C

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using yttrium Y 90 glass microspheres; laboratory biomarker analysis

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Humanitarian Device Exemption Treatment Protocol of TheraSpherer For Treatment of Unresectable Hepatocellular Carcinoma.
yttrium Y 90 glass microspheres; laboratory biomarker analysis

Adult Primary Hepatocellular Carcinoma, Adult Primary Undifferent Clinical Trial using sorafenib tosylate; laboratory biomarker analysis

Roswell Park Cancer Institute - Recruiting N/A or older.
- Granzyme B Production as a Biomarker for the Immunomodulatory Activity of Sorafenib in HCC.
sorafenib tosylate; laboratory biomarker analysis

Adult Acute Lymphoblastic Leukemia in Remission, Adult Nasal Type Clinical Trial using dasatinib; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I Pharmacokinetic Study of Dasatinib (BMS-354825) (NSC-732517; IND-73969) in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction.
dasatinib; pharmacological study

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using tivozanib; pharmacological study; laboratory biomarker analysis

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Multicenter Phase 1b/2 Study of Tivozanib in Patients With Advanced Inoperable Hepatocellular Carcinoma.
tivozanib; pharmacological study; laboratory biomarker analysis

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Li Clinical Trial using stereotactic body radiation therapy

Albert Einstein College of Medicine of Yeshiva University - Recruiting 18 years or older.
- A Pilot Study of Stereotactic Liver Irradiation for Hepatocellular Carcinoma.
stereotactic body radiation therapy